These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26381887)

  • 1. A Risk Score to Guide Cystatin C Testing to Detect Occult-Reduced Estimated Glomerular Filtration Rate.
    Peralta CA; Muntner P; Scherzer R; Judd S; Cushman M; Shlipak MG
    Am J Nephrol; 2015; 42(2):141-7. PubMed ID: 26381887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: A primary care cohort study.
    Shardlow A; McIntyre NJ; Fraser SDS; Roderick P; Raftery J; Fluck RJ; McIntyre CW; Taal MW
    PLoS Med; 2017 Oct; 14(10):e1002400. PubMed ID: 29016597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of Association of Cystatin C With Kidney and Cardiovascular Outcomes by Obesity.
    Chen DC; Scherzer R; Ix JH; Kramer HJ; Crews DC; Nadkarni G; Gutierrez O; Bullen AL; Ilori T; Garimella PS; Shlipak MG; Estrella MM
    Am J Kidney Dis; 2024 Apr; 83(4):489-496.e1. PubMed ID: 37866793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystatin C- and creatinine-based estimated glomerular filtration rate, vascular disease, and mortality in persons with diabetes in the U.S.
    Tsai CW; Grams ME; Inker LA; Coresh J; Selvin E
    Diabetes Care; 2014 Apr; 37(4):1002-8. PubMed ID: 24271191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney Function as Risk Factor and Predictor of Cardiovascular Outcomes and Mortality Among Older Adults.
    Kühn A; van der Giet M; Kuhlmann MK; Martus P; Mielke N; Ebert N; Schaeffner ES
    Am J Kidney Dis; 2021 Mar; 77(3):386-396.e1. PubMed ID: 33197533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine- and cystatin C-based estimates.
    Grams ME; Juraschek SP; Selvin E; Foster MC; Inker LA; Eckfeldt JH; Levey AS; Coresh J
    Am J Kidney Dis; 2013 Aug; 62(2):253-60. PubMed ID: 23619125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between chronic kidney disease detected using creatinine and cystatin C and death and cardiovascular events in elderly Mexican Americans: the Sacramento Area Latino Study on Aging.
    Peralta CA; Lee A; Odden MC; Lopez L; Zeki Al Hazzouri A; Neuhaus J; Haan MN
    J Am Geriatr Soc; 2013 Jan; 61(1):90-5. PubMed ID: 23252993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Estimated GFR Calculated Using Race-Free Equations With Kidney Failure and Mortality by Black vs Non-Black Race.
    Gutiérrez OM; Sang Y; Grams ME; Ballew SH; Surapaneni A; Matsushita K; Go AS; Shlipak MG; Inker LA; Eneanya ND; Crews DC; Powe NR; Levey AS; Coresh J;
    JAMA; 2022 Jun; 327(23):2306-2316. PubMed ID: 35667006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible risk of overestimation of renal function using cystatin C-based eGFR in testicular cancer survivors treated with cisplatin-based chemotherapy.
    Ichioka D; Kawai K; Tanaka K; Ishitsuka R; Yoshino T; Kimura T; Kandori S; Kawahara T; Kojima T; Usui J; Yamagata K; Miyazaki J; Nishiyama H
    Clin Exp Nephrol; 2018 Jun; 22(3):727-734. PubMed ID: 28948387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Intraindividual Difference in Estimated Glomerular Filtration Rate by Creatinine vs Cystatin C and End-stage Kidney Disease and Mortality.
    Chen DC; Shlipak MG; Scherzer R; Bauer SR; Potok OA; Rifkin DE; Ix JH; Muiru AN; Hsu CY; Estrella MM
    JAMA Netw Open; 2022 Feb; 5(2):e2148940. PubMed ID: 35175342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in chronic kidney disease awareness among US adults, 1999 to 2018.
    Hödlmoser S; Winkelmayer WC; Zee J; Pecoits-Filho R; Pisoni RL; Port FK; Robinson BM; Ristl R; Krenn S; Kurnikowski A; Lewandowski M; Ton A; Carrero JJ; Schernhammer ES; Hecking M
    PLoS One; 2020; 15(12):e0243431. PubMed ID: 33338051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Associations of Cystatin C Versus Creatinine-Based Kidney Function With Risks of Cardiovascular Event and Mortality Among South Asian Individuals in the UK Biobank.
    Chen DC; Lees JS; Lu K; Scherzer R; Rutherford E; Mark PB; Kanaya AM; Shlipak MG; Estrella MM
    J Am Heart Assoc; 2023 Feb; 12(3):e027079. PubMed ID: 36695320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystatin C-based estimated glomerular filtration rate and periodontitis.
    Iwasaki M; Taylor GW; Sato M; Nakamura K; Yoshihara A; Miyazaki H
    Gerodontology; 2016 Sep; 33(3):328-34. PubMed ID: 25294234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and determinants of differences in cystatin C and creatinine-based estimated glomerular filtration rate in community-dwelling older adults: a cross-sectional study.
    Legrand H; Werner K; Christensson A; Pihlsgård M; Elmståhl S
    BMC Nephrol; 2017 Dec; 18(1):350. PubMed ID: 29202804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creatinine- versus cystatin C-based renal function assessment in the Northern Manhattan Study.
    Husain SA; Willey JZ; Park Moon Y; Elkind MSV; Sacco RL; Wolf M; Cheung K; Wright CB; Mohan S
    PLoS One; 2018; 13(11):e0206839. PubMed ID: 30427947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure and chronic kidney disease progression in a multi-racial cohort: the Multi-Ethnic Study of Atherosclerosis.
    Bloomfield GS; Yi SS; Astor BC; Kramer H; Shea S; Shlipak MG; Post WS
    J Hum Hypertens; 2013 Jul; 27(7):421-6. PubMed ID: 23407373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of estimated glomerular filtration rate from serum creatinine and cystatin C with new-onset diabetes: a nationwide cohort study in China.
    Zhang Z; He P; Zhou C; Liu M; Liu C; Li H; Zhang Y; Li Q; Zhang Y; Wang G; Liang M; Qin X
    Acta Diabetol; 2021 Sep; 58(9):1269-1276. PubMed ID: 33909121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The difference between cystatin C- and creatinine-based eGFR is associated with adverse cardiovascular outcome in patients with chronic kidney disease.
    Kim H; Park JT; Lee J; Jung JY; Lee KB; Kim YH; Yoo TH; Kang SW; Choi KH; Oh KH; Ahn C; Han SH;
    Atherosclerosis; 2021 Oct; 335():53-61. PubMed ID: 34571286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occult chronic kidney disease among persons with hypertension in the United States: data from the National Health and Nutrition Surveys 1988-1994 and 1999-2002.
    Peralta CA; Weekley CC; Li Y; Shlipak MG
    J Hypertens; 2013 Jun; 31(6):1196-202. PubMed ID: 23640605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Estimated Glomerular Filtration Rate Based on Cystatin C and Grip Strength in Community-Dwelling Japanese Older Adults.
    Kabasawa K; Nakamura K; Ito Y; Tanaka J; Narita I
    J Gerontol A Biol Sci Med Sci; 2021 Aug; 76(9):1653-1660. PubMed ID: 32971533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.